Insider · CIK 0001867952
Joshua M. Murray
Files at CORT (CORCEPT THERAPEUTICS INC), BYND (BEYOND MEAT, INC.). First filing -, latest -.
In brief
Joshua M. Murray files SEC Form 4 as director at CORT (CORCEPT THERAPEUTICS INC), and also at BYND (BEYOND MEAT, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joshua M. Murray has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | May 26, 2026 |
| May 20, 2026 | BYND BEYOND MEAT, INC. | AGrant or award Common Stock | +152,555 | $0.00 | $0 | 202,914 | May 22, 2026 |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 12, 2025 |
Questions about Joshua M. Murray
Answered from the filings on this page, as of the latest one.
Is Joshua M. Murray buying or selling?
Joshua M. Murray has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joshua M. Murray's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joshua M. Murray has 0.
Where does Joshua M. Murray file Form 4?
Joshua M. Murray has filed Form 4 at CORT (CORCEPT THERAPEUTICS INC); BYND (BEYOND MEAT, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.